Monthly Archives: July 2018

Jul 17

Pharmaceutical Research

By Melinda Henderson | Pharmaceutical Research

Pharmacy as a science belonging to the field of Biomedicine and Health and in fact represents the scientific field of this wider scientific area. This affiliation predominantly characterizes pharmacy as a science to which it is the subject of studying human beings and their health, but is more closely focused on studying the medicine, as such.


Thus, pharmacy becomes a multidisciplinary science that includes both basic science advanced knowledge in the field of medicine, chemistry, and biology, as well as some other natural sciences, such as physics, botany, and mathematics. post2aThis definition of pharmacy points to the need for a permanent and comprehensive one the acquisition of knowledge, not only in the field of medicine but also from other related natural sciences, thereby dealing with this doctrine becomes extremely demanding and complicated.


The pharmaceutical industry has always represented, and this is especially the case in the last decades, one of the most burdensome and profitable activities. By introducing the so-called smart medicines that are produced by genetic techniques engineering and procedures used in biotechnology, the need for rapid development and adoption of new knowledge is further emphasized.

Here, it is not only thought of in the field of molecular biology and biotechnology, but at the same time on the ways of delivering and testing the quality of these highly sophisticated drugs, but also on the continuous monitoring of the safety of the use of such drugs.

The necessity of deepening knowledge from each area that is related to the medicine is imposed by the fact that the pharmaceutical industry, after aviation industry, represents another, strictly regulated industry in the world. Although the medicine represents its primary interest, pharmacy is not just a science that deals with finding, designing and producing medications, medicinal preparations, and monitoring and recording their effects and side effects.post2b

In support of this claim, there is a whole series of medical specializations that are traditionally intended for masters of pharmacy, both in our country and abroad. These are Pharmacognosy, Examination and drug control, Pharmaceutical technology, Toxicology chemistry, Medical Biochemistry, Clinical Pharmacy, Sanitary Chemistry, Nutrition and Dietetics, Pharmaceutical Informatics and Pharmacoeconomics and Pharmacy pharmacy.

How it began

The beginnings of pharmacy as an independent profession appear in the cities of the post2cMediterranean where was the influence of the Salerno medical school, the most famous middle age school for the education of doctors and pharmacists. The Sicilian King and Holy Roman Emperor Friedrich II Hohenstaufen brought between 1231 and 1240 the Constitutions, the provisions governing the entire health service in the country.

These provisions introduced major changes in the legislation of the Middle Ages in general and included the part relating to medical medicine on the separation of medicine from a pharmacy. This part is known as the Sicilian Edict (Salerno Edict), which formally separate professions of treatment and preparation of drugs. By introducing these provisions in 1240, the common tree of medicine and pharmacy split into two separate branches, which will further develop independently. The Salerno edict established a model that pharmacy followed throughout Europe.

Jul 17

What David Gibson had to say

By Melinda Henderson | David Gibson

He is a renowned lecturer in Stratified Medicine at the University of Ulster. He is a well-respected doctor who works with numerous Institutes regarding medicine and pharmaceutical research. In addition to the fact that this famous doctor and scientist is not only a guest but also an associate in domestic and international research, projects, and at clinics, David also participates as a visiting writer, lecturer, and blogger on many platforms around the world. He shares his knowledge and research unselfishly with others, wishing that the science he is dealing with is constantly progressing and evolving.

On a conference held last year in a center of Pharmaceutical Research, Gibson spoke not only about the beginnings of medicine and pharmacology, but also about the current state of the world. He addressed not only experts in this field, long-time scientists, doctors, and researchpost1aers, but also all future generations who will deal with some of the branches of this science. His goal was to inspire all those young people who will take part in the future development of Pharmacology and Medicine, to remind all those who are currently dealing with this branch of science about their responsibilities, and possibilities. Part of his speech is transmitted to you in the text below.

How the speech began

According to the results of the research, almost 50 laboratories have patents for most of the drugs used in the world, and these are very important products that often solve the issue of life and death. For years, researchers, including a team from Tufts University and others as Eli Lilly, estimated the cost of improving and developing the drug at a price of 1 billion or more. These estimates attempt to exclude costs that do not directly relate to the authorization of a medicinal product or which do not allow any comparisons between companies.

The pharmaceutical industry strives to preserve and improve the quality of people’s lives. The discovery of the penicillin of Alexander Fleming in the early 20th century created a precondition for the existence of the pharmaceutical industry today. Doctors and pharmacists around the world have thousands of medicines available every day to help improve the treatment and prevention of the most diverse areas.post1b

The pharmaceutical industry is one of the most vital industries with a certain tendency of further growth, estimated at around 900 billion US dollars. There are over 160 pharmaceutical companies with 50 thousand different drugs and medicinal substances. Its further growth implies the consolidation of pharmaceutical companies, the emergence of a large number of generic companies, and the development of small companies whose core activity is the research and development of new pharmaceutical products.

The pharmaceutical market is highly profitable, with an average annual growth rate of around 6 percent at a global level. The United States stands out as a leader with 45 percent of the world market share. European Union countries are also important players in the market with their 29 percent stake.